10x Insights
Loading account…
Companies / Healthcare / Cadre Holdings, Inc.
CDRE

Cadre Holdings, Inc.

HealthcareMedical Instruments
Ticker CDREJACKSONVILLE, FLFiscal year ends DecemberBook value per share $7.99Diluted shares 43.4M

Cadre Holdings, Inc. (NYSE: CDRE) operates as a global leader in manufacturing and distributing safety equipment and protective solutions for law enforcement, first responders, military, and nuclear markets. The company maintains its headquarters in Jacksonville, Florida and operates manufacturing facilities across… From the company’s description.

Fiscal year 2025 · ends 12-31Changes are against fiscal 2024The amber dot is the latest twelve months, to 2026-06-30
Sales & profitability
$610.31M
+7.5% year over year
Last 12 mo $685.65M
11.04%
−0.7 percentage points
Last 12 mo 10.07%
$44.14M
+22.2% year over year
Last 12 mo $36.06M
15.34%
+2.7 percentage points
Last 12 mo 10.40%
Cash & financing
$63.70M
+100.5% year over year
Last 12 mo $88.38M
$56.85M
+117.7% year over year
Last 12 mo $78.12M
0.97
Was 0.72× a year earlier
Last 12 mo 1.08
43.4M
+7.7% year over year
Last 12 mo 43.4M

Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.

What Cadre Holdings, Inc. does

In the company’s own words

Cadre Holdings, Inc. (NYSE: CDRE) operates as a global leader in manufacturing and distributing safety equipment and protective solutions for law enforcement, first responders, military, and nuclear markets. The company maintains its headquarters in Jacksonville, Florida and operates manufacturing facilities across North America and Europe, serving customers in over 100 countries. Cadre employs 2,533 people across its operations, including 1,805 in manufacturing, 236 in sales and marketing, 219 in research and development, and 211 in corporate functions.

The company's product portfolio spans four primary categories. Body armor offerings include concealable, tactical, and corrections armor sold under the Safariland and Protech Tactical brand names, with products designed to meet National Institute of Justice standards. Explosive ordnance disposal solutions, marketed under the Med-Eng brand, comprise operator suits, remotely operated vehicles, specialty tools, and blast sensors serving bomb technicians globally. Duty gear includes holsters and officer equipment sold under Safariland, Radar, and Bianchi brands. Nuclear safety products through Alpha Safety provide engineered containers, ventilation systems, and technical services for nuclear operations and remediation.

Cadre maintains a diversified customer base with no single customer exceeding ten percent of revenue. The company sells through multiple channels including direct relationships with U.S. federal agencies, state and local law enforcement, international defense ministries, and commercial channels via e-commerce platforms. The company operates 71 domestic and 24 international salespeople supported by owned distribution networks and third-party partners.

The company's competitive positioning rests on superior product quality, extensive intellectual property including 607 patents and pending applications, brand recognition through well-established trademarks, and direct end-user relationships spanning over 23,000 first responders and federal agencies. Over sixty percent of product sales derive from mandated refresh cycles occurring every five to ten years, creating predictable recurring revenue streams. Recent acquisitions including TYR Tactical and Zircaloy have expanded the product portfolio and international presence. The company website is www.cadre-holdings.com.

Company details
Sector
Healthcare
Industry
Medical Instruments
Headquarters
JACKSONVILLE, FL
Fiscal year end
December
CIK
1860543
SIC
3842

Financial performance, year by year

Fiscal 2021–2025 · USD
$-68.56M$137.13M$342.82M$548.52M$754.21M20212022202320242025Last 12 moLast 12 monthsLast 12 months

The full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.

Ownership

Who owns Cadre Holdings, Inc. — and what changed

Funds as of 2026Q2 · superinvestors as of 2026-06-30

181
funds hold it
0 of 35
superinvestors hold it
$434.92M
held by funds, at market
35.0%
of shares held by funds

Largest fund holders · Cadre Holdings, Inc.’s weight in each

0.10%of fund net assets
0.54%of fund net assets
VANGUARD TOTAL STOCK MARKET INDEX FUND
VTI · VANGUARD INDEX FUNDS
0.00%of fund net assets
iShares Russell 2000 ETF
IWM · iShares Trust
0.03%of fund net assets
Fidelity Low-Priced Stock Fund
FLPSX · Fidelity Puritan Trust
0.09%of fund net assets

Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.

Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.

Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.

Connected research

Put this business in context.

Compare this company with peers, find it in your funds and follow its financial history with your connected AI:

  • “How do Cadre Holdings, Inc. and its peers compare on margins and cash generation over ten years?”
  • “Where did five years of Cadre Holdings, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
  • “What changed in Cadre Holdings, Inc.'s last four quarterly filings that the numbers alone won't show?”
See how it works →All research tools with a subscription. Use your own AI account.